<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Eur Psychiatry</journal-id>
<journal-id journal-id-type="iso-abbrev">Eur. Psychiatry</journal-id>
<journal-id journal-id-type="publisher-id">EPA</journal-id>
<journal-title-group>
<journal-title>European Psychiatry : the journal of the Association of European Psychiatrists</journal-title>
</journal-title-group>
<issn pub-type="ppub">0924-9338</issn>
<issn pub-type="epub">1778-3585</issn>
<publisher>
<publisher-name>Cambridge University Press</publisher-name>
<publisher-loc>Cambridge, UK</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">32093803</article-id>
<article-id pub-id-type="pmc">7315878</article-id>
<article-id pub-id-type="doi">10.1192/j.eurpsy.2019.6</article-id>
<article-id pub-id-type="pii">S0924933819000063</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>An atlas of genetic correlations between psychiatric disorders and human blood plasma proteome</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Cheng</surname>
<given-names>Shiqiang</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn01">*</xref>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Guan</surname>
<given-names>Fanglin</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="fn01">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ma</surname>
<given-names>Mei</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Lu</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cheng</surname>
<given-names>Bolun</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Qi</surname>
<given-names>Xin</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Liang</surname>
<given-names>Chujun</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Li</surname>
<given-names>Ping</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kafle</surname>
<given-names>Om Prakash</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wen</surname>
<given-names>Yan</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Feng</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="corresp" rid="cor1"></xref>
</contrib>
</contrib-group>
<aff id="aff1">
<label>1</label>
Key Laboratory of Trace Elements and Endemic Diseases of National Health and Family Planning Commission, School of Public Health, Health Science Center, <institution>Xi’an Jiaotong University</institution>, <city>Xi’an</city>, <country>China</country>; Collaborative Innovation Center of Endemic Diseases and Health Promotion in Silk Road Region, Xi’an Jiaotong University, Xi’an 710061, China</aff>
<aff id="aff2">
<label>2</label>
School of Medicine &amp; Forensics, Health Science Center, <institution>Xi’an Jiaotong University</institution>, <city>Xi’an</city>, <country>China</country>
</aff>
<author-notes>
<corresp id="cor1">Feng Zhang, E-mail: <email>fzhxjtu@mail.xjtu.edu.cn</email></corresp>
<fn fn-type="other" id="fn01">
<label>*</label>
<p>Shiqiang Cheng and Fanglin Guan contributed equally to this work.</p>
</fn>
</author-notes>
<pub-date date-type="collection" iso-8601-date="2020" publication-format="electronic">
<year>2020</year>
</pub-date>
<pub-date date-type="pub" publication-format="electronic">
<day>20</day>
<month>2</month>
<year>2020</year>
</pub-date>
<volume>63</volume>
<issue>1</issue>
<elocation-id>e17</elocation-id>
<history>
<date date-type="received">
<day>19</day>
<month>6</month>
<year>2019</year>
</date>
<date date-type="rev-recd">
<day>10</day>
<month>10</month>
<year>2019</year>
</date>
<date date-type="accepted">
<day>12</day>
<month>10</month>
<year>2019</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s) 2020</copyright-statement>
<copyright-year>2020</copyright-year>
<copyright-holder>The Author(s)</copyright-holder>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/">
<ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">http://creativecommons.org/licenses/by/4.0/</ali:license_ref>
<license-p>This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (<uri xlink:href="(http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</uri>), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
</license>
</permissions>
<self-uri xlink:href="S0924933819000063a.pdf" xlink:title="pdf"></self-uri>
<abstract abstract-type="normal">
<sec id="sec1">
<title>Background.</title>
<p>Psychiatric disorders are a group of complex psychological syndromes with high prevalence. Recent studies observed associations between altered plasma proteins and psychiatric disorders. This study aims to systematically explore the potential genetic relationships between five major psychiatric disorders and more than 3,000 plasma proteins.</p>
</sec>
<sec id="sec2">
<title>Methods.</title>
<p>The genome-wide association study (GWAS) datasets of attention deficiency/hyperactive disorder (ADHD), autism spectrum disorder (ASD), bipolar disorder (BD), schizophrenia (SCZ) and major depressive disorder (MDD) were driven from the Psychiatric GWAS Consortium. The GWAS datasets of 3,283 human plasma proteins were derived from recently published study, including 3,301 study subjects. Linkage disequilibrium score (LDSC) regression analysis were conducted to evaluate the genetic correlations between psychiatric disorders and each of the 3,283 plasma proteins.</p>
</sec>
<sec id="sec3">
<title>Results.</title>
<p>LDSC observed several genetic correlations between plasma proteins and psychiatric disorders, such as ADHD and lysosomal Pro-X carboxypeptidase (<italic>p</italic> value = 0.015), ASD and extracellular superoxide dismutase (Cu-Zn; <italic>p</italic> value = 0.023), BD and alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 6 (<italic>p</italic> value = 0.007), MDD and trefoil factor 1 (<italic>p</italic> value = 0.011), and SCZ and insulin-like growth factor-binding protein 6 (<italic>p</italic> value = 0.011). Additionally, we detected four common plasma proteins showing correlation evidence with both BD and SCZ, such as tumor necrosis factor receptor superfamily member 1B (<italic>p</italic> value = 0.012 for BD, <italic>p</italic> value = 0.011 for SCZ).</p>
</sec>
<sec id="sec4">
<title>Conclusions.</title>
<p>This study provided an atlas of genetic correlations between psychiatric disorders and plasma proteome, providing novel clues for pathogenetic and biomarkers, therapeutic studies of psychiatric disorders.</p>
</sec>
</abstract>
<kwd-group>
<title>Key words</title>
<kwd>Genetic correlation</kwd>
<kwd>genome-wide association study</kwd>
<kwd>linkage disequilibrium score regression</kwd>
<kwd>plasma proteins</kwd>
<kwd>psychiatric disorders</kwd>
</kwd-group>
<kwd-group kwd-group-type="abbreviations">
<title>Abbreviations</title>
<compound-kwd>
<compound-kwd-part content-type="abbrev">ADHD</compound-kwd-part>
<compound-kwd-part content-type="expansion">attention deficiency/hyperactive disorder</compound-kwd-part>
</compound-kwd>
<compound-kwd>
<compound-kwd-part content-type="abbrev">ASD</compound-kwd-part>
<compound-kwd-part content-type="expansion">autism spectrum disorder</compound-kwd-part>
</compound-kwd>
<compound-kwd>
<compound-kwd-part content-type="abbrev">BD</compound-kwd-part>
<compound-kwd-part content-type="expansion">bipolar disorder</compound-kwd-part>
</compound-kwd>
<compound-kwd>
<compound-kwd-part content-type="abbrev">BMP7</compound-kwd-part>
<compound-kwd-part content-type="expansion">bone morphogenetic protein 7</compound-kwd-part>
</compound-kwd>
<compound-kwd>
<compound-kwd-part content-type="abbrev">eQTLs</compound-kwd-part>
<compound-kwd-part content-type="expansion">expression quantitative trait loci</compound-kwd-part>
</compound-kwd>
<compound-kwd>
<compound-kwd-part content-type="abbrev">GWAS</compound-kwd-part>
<compound-kwd-part content-type="expansion">genome-wide association study</compound-kwd-part>
</compound-kwd>
<compound-kwd>
<compound-kwd-part content-type="abbrev">iPSYCH</compound-kwd-part>
<compound-kwd-part content-type="expansion">Lundbeck Foundation Initiative for Integrative Psychiatric Research</compound-kwd-part>
</compound-kwd>
<compound-kwd>
<compound-kwd-part content-type="abbrev">LDSC</compound-kwd-part>
<compound-kwd-part content-type="expansion">linkage disequilibrium score</compound-kwd-part>
</compound-kwd>
<compound-kwd>
<compound-kwd-part content-type="abbrev">MDD</compound-kwd-part>
<compound-kwd-part content-type="expansion">major depressive disorder</compound-kwd-part>
</compound-kwd>
<compound-kwd>
<compound-kwd-part content-type="abbrev">PGC</compound-kwd-part>
<compound-kwd-part content-type="expansion">Psychiatric Genomics Consortium</compound-kwd-part>
</compound-kwd>
<compound-kwd>
<compound-kwd-part content-type="abbrev">POMC</compound-kwd-part>
<compound-kwd-part content-type="expansion">pro-opiomelanocortin</compound-kwd-part>
</compound-kwd>
<compound-kwd>
<compound-kwd-part content-type="abbrev">pQTLs</compound-kwd-part>
<compound-kwd-part content-type="expansion">protein quantitative trait loci</compound-kwd-part>
</compound-kwd>
<compound-kwd>
<compound-kwd-part content-type="abbrev">S1P</compound-kwd-part>
<compound-kwd-part content-type="expansion">sphingosine 1 phosphate</compound-kwd-part>
</compound-kwd>
<compound-kwd>
<compound-kwd-part content-type="abbrev">SCZ</compound-kwd-part>
<compound-kwd-part content-type="expansion">schizophrenia</compound-kwd-part>
</compound-kwd>
<compound-kwd>
<compound-kwd-part content-type="abbrev">TNFR2</compound-kwd-part>
<compound-kwd-part content-type="expansion">tumor necrosis factor receptor 2</compound-kwd-part>
</compound-kwd>
<compound-kwd>
<compound-kwd-part content-type="abbrev">TNFRSF1B</compound-kwd-part>
<compound-kwd-part content-type="expansion">tumor necrosis factor receptor superfamily member 1B</compound-kwd-part>
</compound-kwd>
</kwd-group>
<counts>
<fig-count count="0"></fig-count>
<table-count count="2"></table-count>
<ref-count count="57"></ref-count>
<page-count count="7"></page-count>
</counts>
</article-meta>
</front>
<body>
<sec id="sec5" sec-type="intro">
<title>Introduction</title>
<p>Psychiatric disorders are a group of complex psychological symptoms, mainly characterized by clinically significant deficits in an individuals’ cognition, emotion regulation, and behavior [<xref ref-type="bibr" rid="ref1">1</xref>]. The common psychiatric disorders include the attention deficiency/hyperactive disorder (ADHD), autism spectrum disorder (ASD), bipolar disorder (BD), schizophrenia (SCZ), and major depressive disorder (MDD). Psychiatric disorders have been found commonly, with over a third of people in most countries reporting sufficient criteria to be diagnosed at some points of their lives [<xref ref-type="bibr" rid="ref2">2</xref>]. Epidemiological research has shown that about 3–18% of children suffered psychiatric disorders causing significant functional impairment [<xref ref-type="bibr" rid="ref3">3</xref>].</p>
<p>Psychiatric disorders are considered multifactorial and driven by a combination of biological, psychological, and environmental factors [<xref ref-type="bibr" rid="ref4">4</xref>]. Multiple epidemiological [<xref ref-type="bibr" rid="ref5">5</xref>,<xref ref-type="bibr" rid="ref6">6</xref>] and molecular biological [<xref ref-type="bibr" rid="ref7">7</xref>,<xref ref-type="bibr" rid="ref8">8</xref>] studies have observed shared risk components among various psychiatric disorders. Similar environmental risk factors like physical abuse and neglect have also been found to underlie a range of psychiatric disorders, for instance SCZ and depression [<xref ref-type="bibr" rid="ref9">9</xref>]. Recently, there is a growing body of researches focus on the genetic mechanism of psychiatric disorders. The implication of genetic factors in the pathogenesis of psychiatric disorders has been well documented. For instance, the estimated heritability achieved 80% for SCZ [<xref ref-type="bibr" rid="ref10">10</xref>] and &gt;90% for classic autism [<xref ref-type="bibr" rid="ref11">11</xref>]. Multiple large-scale genetic studies of psychiatric disorders have been conducted and identified multiple susceptibility genes for psychiatric disorders [<xref ref-type="bibr" rid="ref12">12</xref>]. However, the etiology and molecular mechanism of psychiatric disorders remains elusive now.</p>
<p>Plasma proteins (also named blood proteins) are a group of proteins in blood plasma. More than 3,600 plasma proteins have been discovered, functionally implicated in signaling, transport, repair, and defense against infection [<xref ref-type="bibr" rid="ref13">13</xref>]. Altered plasma proteins have been found to be related to multiple human complex diseases including psychiatric disorders [<xref ref-type="bibr" rid="ref14">14</xref>,<xref ref-type="bibr" rid="ref15">15</xref>]. As important intermediate phenotypes, plasma proteins are useful for early disease diagnosis, understanding human physiology, developing health biomarkers, and targeting to therapy [<xref ref-type="bibr" rid="ref16">16</xref>,<xref ref-type="bibr" rid="ref17">17</xref>]. For instance, Hye et al. found that complement factor H and α-2-macroglobulin were specific markers of Alzheimer’s disease [<xref ref-type="bibr" rid="ref18">18</xref>]. More recently, a study suggested that apolipoprotein A-1 could act as a serum marker for the response to lithium treatment in BD [<xref ref-type="bibr" rid="ref19">19</xref>]. However, few efforts were paid to systematically explore the relationships between psychiatric disorders and plasma proteome.</p>
<p>It is well known that gene expression is under genetic control [<xref ref-type="bibr" rid="ref20">20</xref>]. Extensive efforts have been paid to explore the genetic mechanism of gene expression regulation and identified a lot expression quantitative trait loci (eQTLs) [<xref ref-type="bibr" rid="ref21">21</xref>]. Recently, Foss et al. performed a large-scale genome-wide association study of more than 3,000 plasma proteins [<xref ref-type="bibr" rid="ref22">22</xref>]. They identified a group of significant protein quantitative trait loci (pQTLs) associated with plasma proteins levels [<xref ref-type="bibr" rid="ref22">22</xref>]. They also observed that the effects of eQTLs on transcript differed from that on protein levels, which emphasizes the importance of pQTLs studies [<xref ref-type="bibr" rid="ref22">22</xref>].</p>
<p>Recent studies demonstrated the generality of genetic correlations among complex human phenotypes. Linkage disequilibrium score (LDSC) regression is an efficient method and widely used for evaluating the genetic relationships among different human phenotypes [<xref ref-type="bibr" rid="ref23">23</xref>]. Utilizing genome-wide association study (GWAS) summary data, LDSC provides an easy and reliable way to simultaneously screen thousands of traits and find out the real genetic correlations among them [<xref ref-type="bibr" rid="ref24">24</xref>]. Utilizing LDSC, Bulik-Sullivan et al. evaluated 276 genetic correlations among 24 traits, and observed significant genetic correlations between anorexia nervosa and SCZ, anorexia and obesity, and educational attainment and several diseases [<xref ref-type="bibr" rid="ref25">25</xref>]. Duncan et al. suggested that LDSC was an appropriate polygenic methods to estimate the overlapping genetic factors between post‐traumatic stress disorder (PTSD) and SCZ as well as bipolar and MDD [<xref ref-type="bibr" rid="ref26">26</xref>].</p>
<p>In this study, utilizing the latest GWAS data of blood proteins and five common psychiatric disorders from the Psychiatric Genomics Consortium (PGC), LDSC was used to systematically evaluate the genetic relationships between five common psychiatric disorders and human plasma proteome.</p>
</sec>
<sec id="sec6" sec-type="materials">
<title>Materials and Methods</title>
<sec id="sec7" sec-type="other">
<title>GWAS datasets of five psychiatric disorders</title>
<p>The latest GWAS summary data of ADHD (19,099 cases and 34,194 controls), ASD (7,387 cases and 8,567 controls), BD (20,129 cases and 21,524 controls), SCZ (33,426 cases and 32,541 controls), and MDD (135,458 cases and 344,901 controls) were downloaded from the Psychiatric GWAS Consortium (PGC) website (<uri xlink:href="https://www.med.unc.edu/pgc/results-and-downloads">https://www.med.unc.edu/pgc/results-and-downloads</uri>) as discovery samples [<xref ref-type="bibr" rid="ref27">27</xref>–<xref ref-type="bibr" rid="ref30">30</xref>]. Briefly, all study subjects were European whites and diagnosed using research standard diagnoses and expert clinical consensus diagnosis. Genotyping was performed using commercial platform such as Illumina 610K and Affymetrix SNP 6.0 chips. Imputation was conducted using IMPUTE2 against public reference panels such as the 1,000 Genomes Project Phase 2 and Phase 3. Association analysis was conducted using logistic regression model. Detailed description of sample characteristics, experimental design, and statistical analysis can be found in the published studies [<xref ref-type="bibr" rid="ref27">27-30</xref>].</p>
</sec>
<sec id="sec8" sec-type="other">
<title>Cross-disorder GWAS replication data of psychiatric disorders</title>
<p>The latest cross-disorder GWAS of six common psychiatric disorders was derived from the Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH) [<xref ref-type="bibr" rid="ref31">31</xref>]. Briefly, Schork et al. conducted a cross-disorder GWAS of six common psychiatric disorders, including ADHD, anorexia, ASD, affective disorder, BP, and SCZ [<xref ref-type="bibr" rid="ref31">31</xref>]. The total sample size included 65,534 individuals with 46,008 cases and 19,526 controls [<xref ref-type="bibr" rid="ref31">31</xref>]. SNP genotying was performed by Inifinium PsychChip v1.0 array. Imputation was conducted using Impute2 with the 1,000 genomes project phase 3 reference. GWAS summary statistics were computed using logistic regression of the plink software. Age, gender, and 10 principle components of population structure were included as covariates. Detailed description of sample characteristics, genotyping, imputation, experimental design, and statistical analysis can be found in the published studies [<xref ref-type="bibr" rid="ref31">31</xref>].</p>
</sec>
<sec id="sec9" sec-type="other">
<title>pQTL data of human plasma proteome</title>
<p>The GWAS summary data of human plasma proteome were derived from a recently published study [<xref ref-type="bibr" rid="ref13">13</xref>]. Briefly, Sun et al. quantify 3,622 plasma proteins in 3,301 healthy participants from the INTERVAL [<xref ref-type="bibr" rid="ref32">32</xref>] study by using an expanded version of an aptamer-based multiplex protein assay (SOMAscan) [<xref ref-type="bibr" rid="ref13">13</xref>]. The genotyping protocol and quality control for the INTERVAL samples have been described previously in detail [<xref ref-type="bibr" rid="ref33">33</xref>]. Briefly, genotyping was performed on the Affymetrix Axiom UK Biobank genotyping array. Imputation was performed via the Sanger Imputation Server by using a combined 1,000 Genomes Phase 3-UK10K reference panel. Simple linear regression using an additive genetic model was used to test genetic associations. After quality control, the GWAS summary data of 3,283 plasma proteins were used in following genetic correlation analysis. Detailed description of sample characteristics, experimental design, quality control, and statistical analysis can be found in the published studies [<xref ref-type="bibr" rid="ref13">13</xref>].</p>
</sec>
<sec id="sec10" sec-type="other">
<title>Genetic correlation scanning</title>
<p>Following the approach recommended by the developers [<xref ref-type="bibr" rid="ref23">23</xref>,<xref ref-type="bibr" rid="ref34">34</xref>] and previous study [<xref ref-type="bibr" rid="ref25">25</xref>], LDSC software (v1.0.0; <uri xlink:href="https://github.com/bulik/ldsc">https://github.com/bulik/ldsc</uri>) were applied to the GWAS summary data for evaluating the genetic correlations between each of the five psychiatric disorders and each of the 3,283 plasma proteins at first. Using the same method, the significant genetic correlations were further validated using the cross-disorder GWAS replication data. The basic principle of the LDSC approach is to estimate directly from GWAS summary data using the deviation of the observed <italic>χ</italic>
<sup>2</sup> test statistic for a SNP from its expected value under the null hypothesis of no association [<xref ref-type="bibr" rid="ref35">35</xref>]. An SNP tagging more of its neighbors—and, thus, having a higher LD score—is more likely to tag one or more causal sites affecting the phenotype [<xref ref-type="bibr" rid="ref35">35</xref>]. If genetic correlations are statistically and quantitatively significant, then we can determine that total phenotypic correlations cannot be attributed to fully environmental confounders [<xref ref-type="bibr" rid="ref24">24</xref>]. In addition, Anney et al. have demonstrated that LD score regression can distinguish genuine polygenicity from the bias caused by population stratification and cryptic relatedness [<xref ref-type="bibr" rid="ref28">28</xref>]. The European LD scores, calculated from the 1,000 Genomes by the developers, were used in this study [<xref ref-type="bibr" rid="ref28">28</xref>].</p>
</sec>
</sec>
<sec id="sec11" sec-type="results">
<title>Results</title>
<p>LDSC regression observed several genetic correlation signals between plasma proteins and psychiatric disorders with LDSC <italic>p</italic> values &lt;0.05. For ADHD, genetic correlation signals were observed for lysosomal Pro-X carboxypeptidase (coefficient = 0.243, <italic>p</italic> value = 0.015), and alpha-2-antiplasmin (coefficient = 0.274, <italic>p</italic> value = 0.032).</p>
<p>For ASD, genetic correlations were observed for extracellular superoxide dismutase (Cu-Zn; coefficient = 0.530, <italic>p</italic> value = 0.023), hepatitis A virus cellular receptor 1 (coefficient = 0.405, <italic>p</italic> value = 0.031), chromogranin-A (coefficient = 0.409, <italic>p</italic> value = 0.034), pro-opiomelanocortin (POMC; coefficient = 0.523, <italic>p</italic> value = 0.041), cysteine-rich hydrophobic domain-containing protein 2 (coefficient = 0.263, <italic>p</italic> value = 0.043), and trypsin-1 (coefficient = 0.397, <italic>p</italic> value = 0.047).</p>
<p>Nine plasma proteins were detected for BD such as alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 6 (coefficient = 0.419, <italic>p</italic> value = 0.007), tumor necrosis factor receptor superfamily member 1B (coefficient = −0.383, <italic>p</italic> value = 0.012), guanine nucleotide exchange factor VAV3 (coefficient = −0.270, <italic>p</italic> value = 0.018), insulin-like growth factor-binding protein 6 (coefficient = −0.377, <italic>p</italic> value = 0.022), and rho guanine nucleotide exchange factor 10 (coefficient = −0.304, <italic>p</italic> value = 0.022).</p>
<p>For MDD, 12 blood plasma proteins were detected such as trefoil factor 1 (coefficient = −0.287, <italic>p</italic> value = 0.011), bone morphogenetic protein 7 (coefficient = 0.392, <italic>p</italic> value = 0.012), peregrin (coefficient = 0.361, <italic>p</italic> value = 0.013), beta-defensin 118 (coefficient = 0.328, <italic>p</italic> value = 0.014), and Neurensin-1 (coefficient = −0.359, <italic>p</italic> value = 0.026).</p>
<p>For SCZ, 15 blood plasma proteins were detected such as insulin-like growth factor-binding protein 6 (coefficient = −0.396, <italic>p</italic> value = 0.011), cathepsin Z (coefficient = −0.349, <italic>p</italic> value = 0.012), sphingosine kinase 2 (coefficient = 0.212, <italic>p</italic> value = 0.018), tropomyosin alpha-1 chain (coefficient = 0.264, <italic>p</italic> value = 0.021), CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1 (coefficient = 0.269, <italic>p</italic> value = 0.028), and protein nephroblastoma overexpressed (NOV) homolog (coefficient = 0.196, <italic>p</italic> value = 0.028; <xref ref-type="table" rid="tab1">Table 1</xref>).<table-wrap id="tab1" orientation="portrait" position="float"><label>Table 1.</label><caption><p>Genetic correlations analysis results between psychiatric disorders and blood plasma protein (<italic>p</italic> value &lt;0.05)</p></caption><alternatives><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1" width="1*"/><col align="left" span="1" width="1*"/><col align="left" span="1" width="1*"/><col align="left" span="1" width="1*"/></colgroup><thead><tr><th align="center" colspan="1" rowspan="1" valign="bottom">Psychiatric disorders</th><th align="center" colspan="1" rowspan="1" valign="bottom">Blood plasma protein</th><th align="justify" colspan="1" rowspan="1" valign="bottom">Coefficients</th><th align="center" colspan="1" rowspan="1" valign="bottom">
<italic>p</italic> values</th></tr></thead><tbody><tr><td align="center" colspan="1" rowspan="2" valign="middle">ADHD</td><td align="left" colspan="1" rowspan="1" valign="middle">Lysosomal Pro-X carboxypeptidase</td><td align="char" char="." colspan="1" rowspan="1" valign="middle">0.243</td><td align="char" char="." colspan="1" rowspan="1" valign="bottom">0.015</td></tr><tr><td align="left" colspan="1" rowspan="1" valign="middle">Alpha-2-antiplasmin</td><td align="char" char="." colspan="1" rowspan="1" valign="middle">0.274</td><td align="char" char="." colspan="1" rowspan="1" valign="bottom">0.032</td></tr><tr><td align="center" colspan="1" rowspan="6" valign="middle">ASD</td><td align="left" colspan="1" rowspan="1" valign="middle">Extracellular superoxide dismutase (Cu-Zn)</td><td align="char" char="." colspan="1" rowspan="1" valign="middle">0.530</td><td align="char" char="." colspan="1" rowspan="1" valign="middle">0.023</td></tr><tr><td align="left" colspan="1" rowspan="1" valign="middle">Hepatitis A virus cellular receptor 1</td><td align="char" char="." colspan="1" rowspan="1" valign="middle">0.405</td><td align="char" char="." colspan="1" rowspan="1" valign="middle">0.031</td></tr><tr><td align="left" colspan="1" rowspan="1" valign="middle">Chromogranin-A</td><td align="char" char="." colspan="1" rowspan="1" valign="middle">0.409</td><td align="char" char="." colspan="1" rowspan="1" valign="middle">0.034</td></tr><tr><td align="left" colspan="1" rowspan="1" valign="middle">Pro-opiomelanocortin</td><td align="char" char="." colspan="1" rowspan="1" valign="middle">0.523</td><td align="char" char="." colspan="1" rowspan="1" valign="middle">0.041</td></tr><tr><td align="left" colspan="1" rowspan="1" valign="middle">Cysteine-rich hydrophobic domain-containing protein 2</td><td align="char" char="." colspan="1" rowspan="1" valign="middle">0.263</td><td align="char" char="." colspan="1" rowspan="1" valign="middle">0.043</td></tr><tr><td align="left" colspan="1" rowspan="1" valign="middle">Trypsin-1</td><td align="char" char="." colspan="1" rowspan="1" valign="middle">0.370</td><td align="char" char="." colspan="1" rowspan="1" valign="middle">0.047</td></tr><tr><td align="center" colspan="1" rowspan="8" valign="middle">BD</td><td align="left" colspan="1" rowspan="1" valign="middle">Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 6</td><td align="char" char="." colspan="1" rowspan="1" valign="middle">0.419</td><td align="char" char="." colspan="1" rowspan="1" valign="middle">0.007</td></tr><tr><td align="left" colspan="1" rowspan="1" valign="middle">Tumor necrosis factor receptor superfamily member 1B</td><td align="char" char="." colspan="1" rowspan="1" valign="middle">−0.383</td><td align="char" char="." colspan="1" rowspan="1" valign="middle">0.012</td></tr><tr><td align="left" colspan="1" rowspan="1" valign="middle">Guanine nucleotide exchange factor VAV3</td><td align="char" char="." colspan="1" rowspan="1" valign="middle">−0.270</td><td align="char" char="." colspan="1" rowspan="1" valign="middle">0.018</td></tr><tr><td align="left" colspan="1" rowspan="1" valign="middle">Insulin-like growth factor-binding protein 6</td><td align="char" char="." colspan="1" rowspan="1" valign="middle">−0.377</td><td align="char" char="." colspan="1" rowspan="1" valign="middle">0.022</td></tr><tr><td align="left" colspan="1" rowspan="1" valign="middle">Rho guanine nucleotide exchange factor 10</td><td align="char" char="." colspan="1" rowspan="1" valign="middle">−0.304</td><td align="char" char="." colspan="1" rowspan="1" valign="middle">0.022</td></tr><tr><td align="left" colspan="1" rowspan="1" valign="middle">Sodium-coupled monocarboxylate transporter 1.sumstats</td><td align="char" char="." colspan="1" rowspan="1" valign="middle">−0.210</td><td align="char" char="." colspan="1" rowspan="1" valign="middle">0.027</td></tr><tr><td align="left" colspan="1" rowspan="1" valign="middle">Normal mucosa of esophagus-specific gene 1 protein</td><td align="char" char="." colspan="1" rowspan="1" valign="middle">−0.215</td><td align="char" char="." colspan="1" rowspan="1" valign="middle">0.030</td></tr><tr><td align="left" colspan="1" rowspan="1" valign="middle">Muscle, skeletal receptor tyrosine-protein kinase</td><td align="char" char="." colspan="1" rowspan="1" valign="middle">−0.200</td><td align="char" char="." colspan="1" rowspan="1" valign="middle">0.033</td></tr><tr><td align="center" colspan="1" rowspan="13" valign="middle">MDD</td><td align="left" colspan="1" rowspan="1" valign="middle">Trefoil factor 1</td><td align="char" char="." colspan="1" rowspan="1" valign="middle">−0.287</td><td align="char" char="." colspan="1" rowspan="1" valign="middle">0.011</td></tr><tr><td align="left" colspan="1" rowspan="1" valign="middle">Bone morphogenetic protein 7</td><td align="char" char="." colspan="1" rowspan="1" valign="middle">0.392</td><td align="char" char="." colspan="1" rowspan="1" valign="middle">0.012</td></tr><tr><td align="left" colspan="1" rowspan="1" valign="middle">Peregrin</td><td align="char" char="." colspan="1" rowspan="1" valign="middle">0.361</td><td align="char" char="." colspan="1" rowspan="1" valign="middle">0.013</td></tr><tr><td align="left" colspan="1" rowspan="1" valign="middle">Beta-defensin 118</td><td align="char" char="." colspan="1" rowspan="1" valign="middle">0.328</td><td align="char" char="." colspan="1" rowspan="1" valign="middle">0.014</td></tr><tr><td align="left" colspan="1" rowspan="1" valign="middle">Neurensin-1</td><td align="char" char="." colspan="1" rowspan="1" valign="middle">−0.359</td><td align="char" char="." colspan="1" rowspan="1" valign="middle">0.026</td></tr><tr><td align="left" colspan="1" rowspan="1" valign="middle">Multimerin-2</td><td align="char" char="." colspan="1" rowspan="1" valign="middle">0.322</td><td align="char" char="." colspan="1" rowspan="1" valign="middle">0.026</td></tr><tr><td align="left" colspan="1" rowspan="1" valign="middle">Matrix metalloproteinase-17</td><td align="char" char="." colspan="1" rowspan="1" valign="middle">0.358</td><td align="char" char="." colspan="1" rowspan="1" valign="middle">0.026</td></tr><tr><td align="left" colspan="1" rowspan="1" valign="middle">Intercellular adhesion molecule 3</td><td align="char" char="." colspan="1" rowspan="1" valign="middle">0.241</td><td align="char" char="." colspan="1" rowspan="1" valign="middle">0.036</td></tr><tr><td align="left" colspan="1" rowspan="1" valign="middle">Tumor necrosis factor receptor superfamily member 8</td><td align="char" char="." colspan="1" rowspan="1" valign="middle">0.297</td><td align="char" char="." colspan="1" rowspan="1" valign="middle">0.040</td></tr><tr><td align="left" colspan="1" rowspan="1" valign="middle">Neurotensin/neuromedin N</td><td align="char" char="." colspan="1" rowspan="1" valign="middle">0.313</td><td align="char" char="." colspan="1" rowspan="1" valign="middle">0.041</td></tr><tr><td align="left" colspan="1" rowspan="1" valign="middle">Cyclin-dependent kinase 2:Cyclin-A2 complex</td><td align="char" char="." colspan="1" rowspan="1" valign="middle">0.443</td><td align="char" char="." colspan="1" rowspan="1" valign="middle">0.045</td></tr><tr><td align="left" colspan="1" rowspan="1" valign="middle">Glyceraldehyde-3-phosphate dehydrogenase, testis-specific</td><td align="char" char="." colspan="1" rowspan="1" valign="middle">−0.336</td><td align="char" char="." colspan="1" rowspan="1" valign="middle">0.048</td></tr><tr><td align="left" colspan="1" rowspan="1" valign="middle">Trefoil factor 1</td><td align="char" char="." colspan="1" rowspan="1" valign="middle">−0.287</td><td align="char" char="." colspan="1" rowspan="1" valign="middle">0.011</td></tr><tr><td align="center" colspan="1" rowspan="15" valign="middle">SCZ</td><td align="left" colspan="1" rowspan="1" valign="middle">Insulin-like growth factor-binding protein 6</td><td align="char" char="." colspan="1" rowspan="1" valign="middle">−0.396</td><td align="char" char="." colspan="1" rowspan="1" valign="middle">0.011</td></tr><tr><td align="left" colspan="1" rowspan="1" valign="middle">Cathepsin Z</td><td align="char" char="." colspan="1" rowspan="1" valign="middle">−0.349</td><td align="char" char="." colspan="1" rowspan="1" valign="middle">0.012</td></tr><tr><td align="left" colspan="1" rowspan="1" valign="middle">Sphingosine kinase 2</td><td align="char" char="." colspan="1" rowspan="1" valign="middle">0.212</td><td align="char" char="." colspan="1" rowspan="1" valign="middle">0.018</td></tr><tr><td align="left" colspan="1" rowspan="1" valign="middle">Tropomyosin alpha-1 chain</td><td align="char" char="." colspan="1" rowspan="1" valign="middle">0.264</td><td align="char" char="." colspan="1" rowspan="1" valign="middle">0.021</td></tr><tr><td align="left" colspan="1" rowspan="1" valign="middle">CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1</td><td align="char" char="." colspan="1" rowspan="1" valign="middle">0.269</td><td align="char" char="." colspan="1" rowspan="1" valign="middle">0.028</td></tr><tr><td align="left" colspan="1" rowspan="1" valign="middle">Protein NOV homolog</td><td align="char" char="." colspan="1" rowspan="1" valign="middle">0.196</td><td align="char" char="." colspan="1" rowspan="1" valign="middle">0.028</td></tr><tr><td align="left" colspan="1" rowspan="1" valign="middle">Normal mucosa of esophagus-specific gene 1 protein</td><td align="char" char="." colspan="1" rowspan="1" valign="middle">−0.167</td><td align="char" char="." colspan="1" rowspan="1" valign="middle">0.030</td></tr><tr><td align="left" colspan="1" rowspan="1" valign="middle">Alpha-L-iduronidase</td><td align="char" char="." colspan="1" rowspan="1" valign="middle">−0.260</td><td align="char" char="." colspan="1" rowspan="1" valign="middle">0.032</td></tr><tr><td align="left" colspan="1" rowspan="1" valign="middle">Potassium voltage-gated channel subfamily E member 2</td><td align="char" char="." colspan="1" rowspan="1" valign="middle">0.182</td><td align="char" char="." colspan="1" rowspan="1" valign="middle">0.039</td></tr><tr><td align="left" colspan="1" rowspan="1" valign="middle">Cell surface glycoprotein CD200 receptor 2</td><td align="char" char="." colspan="1" rowspan="1" valign="middle">−0.233</td><td align="char" char="." colspan="1" rowspan="1" valign="middle">0.041</td></tr><tr><td align="left" colspan="1" rowspan="1" valign="middle">Profilin-2</td><td align="char" char="." colspan="1" rowspan="1" valign="middle">−0.329</td><td align="char" char="." colspan="1" rowspan="1" valign="middle">0.042</td></tr><tr><td align="left" colspan="1" rowspan="1" valign="middle">Ubiquitin-conjugating enzyme E2 T</td><td align="char" char="." colspan="1" rowspan="1" valign="middle">0.264</td><td align="char" char="." colspan="1" rowspan="1" valign="middle">0.043</td></tr><tr><td align="left" colspan="1" rowspan="1" valign="middle">Rho guanine nucleotide exchange factor 10</td><td align="char" char="." colspan="1" rowspan="1" valign="middle">−0.229</td><td align="char" char="." colspan="1" rowspan="1" valign="middle">0.044</td></tr><tr><td align="left" colspan="1" rowspan="1" valign="middle">Tumor necrosis factor receptor superfamily member 1B</td><td align="char" char="." colspan="1" rowspan="1" valign="middle">−0.292</td><td align="char" char="." colspan="1" rowspan="1" valign="middle">0.045</td></tr><tr><td align="left" colspan="1" rowspan="1" valign="middle">Disintegrin and metalloproteinase domain-containing protein 29</td><td align="char" char="." colspan="1" rowspan="1" valign="middle">0.272</td><td align="char" char="." colspan="1" rowspan="1" valign="middle">0.048</td></tr></tbody></table><graphic xlink:href="S0924933819000063_tab1"></graphic></alternatives><table-wrap-foot><p>Abbreviations: ADHD, attention deficiency/hyperactive disorder; ASD, autism spectrum disorder; BD, bipolar disorder; MDD, major depressive disorder; SCZ, schizophrenia.</p></table-wrap-foot></table-wrap></p>
<p>After comparing the LDSC results of the five psychiatric disorders, we also detected four common plasma proteins shared by BD and SCZ, including tumor necrosis factor receptor superfamily member 1B (<italic>p</italic> value = 0.012 for BD, <italic>p</italic> value = 0.011 for SCZ), insulin-like growth factor-binding protein 6 (<italic>p</italic> value = 0.022 for BD, <italic>p</italic> value = 0.030 for SCZ), rho guanine nucleotide exchange factor 10 (<italic>p</italic> value = 0.022 for BD, <italic>p</italic> value = 0.044 for SCZ), and normal mucosa of esophagus-specific gene 1 protein (<italic>p</italic> value = 0.030 for BD, <italic>p</italic> value = 0.045 for SCZ; <xref ref-type="table" rid="tab2">Table 2</xref>).<table-wrap id="tab2" orientation="portrait" position="float"><label>Table 2.</label><caption><p>Common genetic correlations between psychiatric disorders and plasma protein (<italic>p</italic> &lt; 0.05).</p></caption><alternatives><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1" width="1*"/><col align="left" span="1" width="1*"/><col align="left" span="1" width="1*"/></colgroup><thead><tr><th align="center" colspan="1" rowspan="2" valign="bottom">Blood plasma protein</th><th align="center" colspan="2" rowspan="1" valign="bottom">
<italic>p</italic> values</th></tr><tr><th align="center" colspan="1" rowspan="1" valign="bottom">BD</th><th align="center" colspan="1" rowspan="1" valign="bottom">SCZ</th></tr></thead><tbody><tr><td align="justify" colspan="1" rowspan="1" valign="top">Tumor necrosis factor receptor superfamily member 1B</td><td align="center" colspan="1" rowspan="1" valign="top">0.012</td><td align="center" colspan="1" rowspan="1" valign="top">0.011</td></tr><tr><td align="justify" colspan="1" rowspan="1" valign="top">Insulin-like growth factor-binding protein 6</td><td align="center" colspan="1" rowspan="1" valign="top">0.022</td><td align="center" colspan="1" rowspan="1" valign="top">0.030</td></tr><tr><td align="justify" colspan="1" rowspan="1" valign="top">Rho guanine nucleotide exchange factor 10</td><td align="center" colspan="1" rowspan="1" valign="top">0.022</td><td align="center" colspan="1" rowspan="1" valign="top">0.044</td></tr><tr><td align="justify" colspan="1" rowspan="1" valign="top">Normal mucosa of esophagus-specific gene 1 protein</td><td align="center" colspan="1" rowspan="1" valign="top">0.030</td><td align="center" colspan="1" rowspan="1" valign="top">0.045</td></tr></tbody></table><graphic xlink:href="S0924933819000063_tab2"></graphic></alternatives><table-wrap-foot><p>Abbreviations: BD, bipolar disorder; SCZ, schizophrenia.</p></table-wrap-foot></table-wrap></p>
<p>The significant genetic correlations detected in the discovery GWAS datasets of five psychiatric disorders were further validated in the cross-disorder replication GWAS data. Two proteins identified in the discovery GWAS were further replicated in the cross-disorder replication GWAS data including multimerin-2 (coefficient = 0.471, <italic>p</italic> value = 0.032) and tumor necrosis factor receptor superfamily member 8 (coefficient = 0.388, <italic>p</italic> value = 0.033).</p>
</sec>
<sec id="sec12" sec-type="discussion">
<title>Discussion</title>
<p>To provide an atlas of genetic correlations between psychiatric disorders and plasma proteins, we conducted a large-scale genetic correlations between five common psychiatric disorders and 3,283 plasma proteins. We observed modest genetic correlations and identified several plasma proteins showing genetic correlation evidence with the five psychiatric disorders. Our study results provide novel clues for the pathogenetic and biomarkers studies of common psychiatric disorders.</p>
<p>We found that POMC was correlated with autism, which was consistent with previous study [<xref ref-type="bibr" rid="ref36">36</xref>]. POMC is a precursor polypeptide with 241 amino acid residues, and cleave to give rise to multiple peptide hormones. Previous studies of adult individuals exhibiting self-injurious behavior suggested that the pro-opiomelanocortin system, especially the endogenous opioid system, was dysregulated in the subgroups of autistic patients [<xref ref-type="bibr" rid="ref37">37</xref>,<xref ref-type="bibr" rid="ref38">38</xref>]. Cazzullo et al. have suggested that the concentration of plasma POMC fragments, especially opioid fragments, contributed to the symptoms of autism as well as the response to treatment [<xref ref-type="bibr" rid="ref39">39</xref>]. A mutation in the opioid region of the POMC gene in an autistic individual indicated that a subgroup of patients will be identified who share a POMC genetic defect [<xref ref-type="bibr" rid="ref40">40</xref>,<xref ref-type="bibr" rid="ref41">41</xref>].</p>
<p>Bone morphogenetic protein 7 (BMP7), a member of the transforming growth factor-β superfamily, is another notable finding of this study. BMP7 plays a critical role in the development of noradrenergic neurons. It has neurotrophic and neuroprotective effects on mature catecholaminergic neurons [<xref ref-type="bibr" rid="ref42">42</xref>,<xref ref-type="bibr" rid="ref43">43</xref>]. Real-time polymerase chain reaction (PCR) of locus coeruleus tissue from 12 matched pairs of MDD subjects and psychiatrically normal control subjects revealed low levels of BMP7 gene expression in MDD [<xref ref-type="bibr" rid="ref44">44</xref>]. Laser capture microdissection of noradrenergic neurons, astrocytes, and oligodendrocytes from the locus coeruleus revealed that the MDD-associated reduction in BMP7 gene expression was limited to astrocytes [<xref ref-type="bibr" rid="ref44">44</xref>]. This suggests that reduced astrocyte support for pontine locus coeruleus neurons may contribute to pathology of brain noradrenergic neurons in MDD [<xref ref-type="bibr" rid="ref44">44</xref>]. Rats exposed to chronic social defeat exhibited a similar reduction in BMP7 gene expression in the locus coeruleus [<xref ref-type="bibr" rid="ref44">44</xref>].</p>
<p>The defects responsible for impaired sensorimotor gating in mice, a hallmark of SCZ, might include myelination dysregulation, which has been observed in some cases of human SCZ [<xref ref-type="bibr" rid="ref45">45</xref>,<xref ref-type="bibr" rid="ref46">46</xref>]. Notably, sphingosine 1 phosphate (S1P) receptor expression in oligodendrocytes involves in the process of myelination in the rodent central nervous system and might contribute to glial differentiation, maturation, and myelination during development [<xref ref-type="bibr" rid="ref47">47</xref>]. Contos et al. suggested that constitutive knockout of S1P receptor 1 causes a behavioral phenotype reminiscent of SCZ [<xref ref-type="bibr" rid="ref48">48</xref>]. The concentration of S1P is regulated by the activities of two kinases—sphingosine kinase 1 and 2, a number of broad specificity lipid phosphate phosphatases which have a selectivity toward S1P [<xref ref-type="bibr" rid="ref49">49</xref>]. In this study, we found that sphingosine kinase 2 was correlated with SCZ, which is consistent with previous conclusions.</p>
<p>Additionally, we observed genetic correlation evidence between guanine nucleotide exchange factor 3 VAV3 (VAV3) and BD. A study including 199 participants from the Mayo Clinic Bipolar Disorder Biobank suggested that several SNPs of VAV3 gene was associated with the response to antiepileptic drugs-mood stabilizers in BD patients [<xref ref-type="bibr" rid="ref50">50</xref>]. Previous molecular biological studies have found multiple shared risk components between BD and SCZ [<xref ref-type="bibr" rid="ref5">5</xref>,<xref ref-type="bibr" rid="ref7">7</xref>]. It is interesting that we found common proteins shown significant genetic correlations between BD and SCZ in this study, for instance tumor necrosis factor receptor superfamily member 1B (TNFRSF1B). TNFRSF1B, also known as tumor necrosis factor receptor 2 (TNFR2), is a membrane receptor that binds tumor necrosis factor-alpha. TNFRSF1B is expressed in glia and neurons [<xref ref-type="bibr" rid="ref51">51</xref>]. It has been reported that TNFRSF1B mediated trophic or protective role in neuronal survival [<xref ref-type="bibr" rid="ref52">52</xref>]. TNFRSF1B knockout studies in mice suggested a role of TNFRSF1B in protecting neurons from apoptosis by stimulating antioxidative pathways [<xref ref-type="bibr" rid="ref53">53</xref>]. Till et al. suggested that the polymorphism of TNFRSF1B gene resulted in a lower capability to induce NF-kB activation, leading to an enhancement of TNFR1-induced apoptosis [<xref ref-type="bibr" rid="ref54">54</xref>]. SCZ patients with 676G allele of TNFRSF1B have a decreased neuron survival, dendritic branching, and capacity of remyelination [<xref ref-type="bibr" rid="ref55">55</xref>]. Compared with healthy control subjects, SCZ and BD patients have higher plasma soluble TNFRSF1B levels [<xref ref-type="bibr" rid="ref56">56</xref>]. This could be interpreted as the increasing in soluble TNFRSF1B levels to reduce apoptosis and modulate TNF activity in the euthymic period in BD [<xref ref-type="bibr" rid="ref57">57</xref>]. Based on the previous and our study results, it is reasonable to infer that the observed negative genetic correlations between TNFRSF1B and BD/SCZ may partially be explained by the protective effects of TNFRSF1B on neurons. Further studies are needed to confirm the role of TNFRSF1B in the pathological mechanisms of BD and SCZ.</p>
<p>To the best of our knowledge, this is the first large-scale genetic correlation analysis of plasma proteome and psychiatric disorders. Because of using GWAS genetic data, our study results should be less susceptible to environmental confounding factors. Notably, two limitations of our approach should also be noted. First, it should be noted that the objective of this study is to evaluate the genetic correlations between plasma proteome and psychiatric disorders, and to scan novel candidate plasma proteins related to psychiatric disorders. Further functional studies are needed to confirm our findings and clarify the potential biological mechanisms of observed associations between plasma proteins and psychiatric disorders in this study. Second, the GWAS summary data of this study are all from European ancestry. Therefore, it should be careful to apply our study results to other ethnic groups.</p>
</sec>
<sec id="sec13" sec-type="conclusions">
<title>Conclusions</title>
<p>In summary, by utilizing LDSC approach, we conducted a large-scale analysis to investigate the genetic correlations between blood plasma proteome and psychiatric disorders. Our study identified a set of candidate plasma proteins showing association signals with psychiatric disorders. We hope that our findings will provide novel insights into the future pathogenetic studies of psychiatric disorders and serve as a fundamental resource for understanding the genetic mechanisms of the effects of plasma proteome on psychiatric disorders.</p>
</sec>
</body>
<back>
<ack>
<sec id="sec15" sec-type="COI-statement">
<title>Conflicts of Interest.</title>
<p>The authors have stated that they have no conflict of interest.</p>
</sec>
</ack>
<sec id="sec14" sec-type="other">
<title>Funding.</title>
<p>This study is supported by the National Natural Scientific Foundation of China (81472925, 81673112), the Key Projects of International Cooperation Among Governments in Scientific and Technological Innovation (2016YFE0119100), the Natural Science Basic Research Plan in Shaanxi Province of China (2017JZ024), and the Fundamental Research Funds for the Central Universities.</p>
</sec>
<sec id="sec16" sec-type="other">
<title>Authorship Contributions.</title>
<p>S.C. and F.Z. conceived and designed the study, wrote the manuscript, collected the data, and carried out the statistical analyses; F.G., M.M., L.Z., B.C., X.Q., C.L., P.L., O.P.K., and Y.W. made preparations for the manuscript at first. All authors reviewed and approved the final manuscript.</p>
</sec>
<ref-list id="refs1">
<title>References</title>
<ref id="r1">
<label>[1]</label>
<mixed-citation id="ref1" publication-type="book"><collab>American Psychiatric Association</collab>. <source/>Diagnostic and statistical manual of mental disorders (DSM-5®). <publisher-loc>Arlington, VA</publisher-loc>: <publisher-name>American Psychiatric Publishing</publisher-name>, <year>2013</year>.</mixed-citation>
</ref>
<ref id="r2">
<label>[2]</label>
<mixed-citation id="ref2" publication-type="journal"><string-name><surname>Andrade</surname>
<given-names>LH</given-names></string-name>, <string-name><surname>Caraveoanduaga</surname>
<given-names>JJ</given-names></string-name>, <string-name><surname>Berglund</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Bijl</surname>
<given-names>RV</given-names></string-name>, <string-name><surname>Kessler</surname>
<given-names>RC</given-names></string-name>, <string-name><surname>Demler</surname>
<given-names>O</given-names></string-name>, <etal>et al.</etal>
<article-title>Cross-national comparisons of the prevalences and correlates of mental disorders</article-title>. <source/>Bull World Health Organ. <year>2000</year>;<volume>78</volume>:<fpage>413</fpage>–<lpage>425</lpage>.<pub-id pub-id-type="pmid">10885160</pub-id></mixed-citation>
</ref>
<ref id="r3">
<label>[3]</label>
<mixed-citation id="ref3" publication-type="journal"><string-name><surname>Costello</surname>
<given-names>EJ</given-names></string-name>, <string-name><surname>Egger</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Angold</surname>
<given-names>A</given-names></string-name>. <article-title>10-Year research update review: the epidemiology of child and adolescent psychiatric disorders: I. Methods and public health burden</article-title>. <source/>J Am Acad Child Adolesc Psychiatry. <year>2005</year>;<volume>44</volume>(<issue>10</issue>):<fpage>972</fpage>–<lpage>986</lpage>.<pub-id pub-id-type="pmid">16175102</pub-id></mixed-citation>
</ref>
<ref id="r4">
<label>[4]</label>
<mixed-citation id="ref4" publication-type="journal"><string-name><surname>Arango</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Diazcaneja</surname>
<given-names>CM</given-names></string-name>, <string-name><surname>Mcgorry</surname>
<given-names>PD</given-names></string-name>, <string-name><surname>Rapoport</surname>
<given-names>JL</given-names></string-name>, <string-name><surname>Sommer</surname>
<given-names>IEC</given-names></string-name>, <string-name><surname>Vorstman</surname>
<given-names>J</given-names></string-name>, <etal>et al.</etal>
<article-title>Preventive strategies for mental health</article-title>. <source/>Lancet Psychiatry. <year>2018</year>;<volume>5</volume>(<issue>7</issue>):<fpage>591</fpage>–<lpage>604</lpage>.<pub-id pub-id-type="pmid">29773478</pub-id></mixed-citation>
</ref>
<ref id="r5">
<label>[5]</label>
<mixed-citation id="ref5" publication-type="journal"><string-name><surname>Lichtenstein</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Yip</surname>
<given-names>BH</given-names></string-name>, <string-name><surname>Björk</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Pawitan</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Cannon</surname>
<given-names>TD</given-names></string-name>, <string-name><surname>Sullivan</surname>
<given-names>PF</given-names></string-name>, <etal>et al.</etal>
<article-title>Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study</article-title>. <source/>Lancet. <year>2009</year>;<volume>373</volume>(<issue>9659</issue>):<fpage>234</fpage>–<lpage>239</lpage>.<pub-id pub-id-type="pmid">19150704</pub-id></mixed-citation>
</ref>
<ref id="r6">
<label>[6]</label>
<mixed-citation id="ref6" publication-type="journal"><string-name><surname>McGuffin</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Rijsdijk</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Andrew</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Sham</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Katz</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Cardno</surname>
<given-names>A</given-names></string-name>. <article-title>The heritability of bipolar affective disorder and the genetic relationship to unipolar depression</article-title>. <source/>Arch Gen Psychiatry. <year>2003</year>;<volume>60</volume>(<issue>5</issue>):<fpage>497</fpage>–<lpage>502</lpage>.<pub-id pub-id-type="pmid">12742871</pub-id></mixed-citation>
</ref>
<ref id="r7">
<label>[7]</label>
<mixed-citation id="ref7" publication-type="journal"><string-name><surname>Smoller</surname>
<given-names>JW</given-names></string-name>, <string-name><surname>Kendler</surname>
<given-names>KS</given-names></string-name>, <string-name><surname>Craddock</surname>
<given-names>NJ</given-names></string-name>, <string-name><surname>Lee</surname>
<given-names>PH</given-names></string-name>, <string-name><surname>Neale</surname>
<given-names>BM</given-names></string-name>, <string-name><surname>Nurnberger</surname>
<given-names>JI</given-names></string-name>, <etal>et al.</etal>
<article-title>Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis</article-title>. <source/>Lancet. <year>2013</year>;<volume>381</volume>(<issue>9875</issue>):<fpage>1371</fpage>–<lpage>1379</lpage>.<pub-id pub-id-type="pmid">23453885</pub-id></mixed-citation>
</ref>
<ref id="r8">
<label>[8]</label>
<mixed-citation id="ref8" publication-type="journal"><collab>Bipolar Disorder Genome Study (BiGS) Consortium</collab>, <string-name><surname>McMahon</surname>
<given-names>FJ</given-names></string-name>, <string-name><surname>Akula</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Schulze</surname>
<given-names>TG</given-names></string-name>, <string-name><surname>Muglia</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Tozzi</surname>
<given-names>F</given-names></string-name>, <etal>et al.</etal>
<article-title>Meta-analysis of genome-wide association data identifies a risk locus for major mood disorders on 3p21.1</article-title>. <source/>Nat Genet. <year>2010</year>;<volume>42</volume>:<fpage>128</fpage>.<pub-id pub-id-type="pmid">20081856</pub-id></mixed-citation>
</ref>
<ref id="r9">
<label>[9]</label>
<mixed-citation id="ref9" publication-type="journal"><string-name><surname>Keyes</surname>
<given-names>KM</given-names></string-name>, <string-name><surname>Eaton</surname>
<given-names>NR</given-names></string-name>, <string-name><surname>Krueger</surname>
<given-names>RF</given-names></string-name>, <string-name><surname>Mclaughlin</surname>
<given-names>KA</given-names></string-name>, <string-name><surname>Wall</surname>
<given-names>MM</given-names></string-name>, <string-name><surname>Grant</surname>
<given-names>BF</given-names></string-name>, <etal>et al.</etal>
<article-title>Childhood maltreatment and the structure of common psychiatric disorders</article-title>. <source/>Br J Psychiatry. <year>2012</year>;<volume>200</volume>(<issue>2</issue>):<fpage>107</fpage>–<lpage>115</lpage>.<pub-id pub-id-type="pmid">22157798</pub-id></mixed-citation>
</ref>
<ref id="r10">
<label>[10]</label>
<mixed-citation id="ref10" publication-type="book"><string-name><surname>McGuffin</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Owen</surname>
<given-names>MJ</given-names></string-name>, <string-name><surname>Gottesman</surname>
<given-names>II</given-names></string-name>. <source/>Psychiatric genetics and genomics II. <publisher-loc>UK</publisher-loc>: <publisher-name>Oxford University Press</publisher-name>, <year>2002</year>.</mixed-citation>
</ref>
<ref id="r11">
<label>[11]</label>
<mixed-citation id="ref11" publication-type="journal"><string-name><surname>Freitag</surname>
<given-names>CM</given-names></string-name>. <article-title>The genetics of autistic disorders and its clinical relevance: a review of the literature</article-title>. <source/>Mol Psychiatry. <year>2006</year>;<volume>12</volume>:<fpage>2</fpage>.<pub-id pub-id-type="pmid">17033636</pub-id></mixed-citation>
</ref>
<ref id="r12">
<label>[12]</label>
<mixed-citation id="ref12" publication-type="journal"><string-name><surname>Gratacòs</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Costas</surname>
<given-names>J</given-names></string-name>, <string-name><surname>de Cid</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Bayés</surname>
<given-names>M</given-names></string-name>, <string-name><surname>González</surname>
<given-names>JR</given-names></string-name>, <string-name><surname>Baca-García</surname>
<given-names>E</given-names></string-name>, <etal>et al.</etal>
<article-title>Identification of new putative susceptibility genes for several psychiatric disorders by association analysis of regulatory and non-synonymous SNPs of 306 genes involved in neurotransmission and neurodevelopment</article-title>. <source/>Am J Med Genet B. <year>2009</year>;<volume>150B</volume>(<issue>6</issue>):<fpage>808</fpage>–<lpage>816</lpage>.</mixed-citation>
</ref>
<ref id="r13">
<label>[13]</label>
<mixed-citation id="ref13" publication-type="journal"><string-name><surname>Sun</surname>
<given-names>BB</given-names></string-name>, <string-name><surname>Maranville</surname>
<given-names>JC</given-names></string-name>, <string-name><surname>Peters</surname>
<given-names>JE</given-names></string-name>, <string-name><surname>Stacey</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Staley</surname>
<given-names>JR</given-names></string-name>, <string-name><surname>Blackshaw</surname>
<given-names>J</given-names></string-name>, <etal>et al.</etal>
<article-title>Genomic atlas of the human plasma proteome</article-title>. <source/>Nature. <year>2018</year>;<volume>558</volume>(<issue>7708</issue>):<fpage>73</fpage>–<lpage>79</lpage>.<pub-id pub-id-type="pmid">29875488</pub-id></mixed-citation>
</ref>
<ref id="r14">
<label>[14]</label>
<mixed-citation id="ref14" publication-type="journal"><string-name><surname>Chan</surname>
<given-names>MK</given-names></string-name>, <string-name><surname>Gottschalk</surname>
<given-names>MG</given-names></string-name>, <string-name><surname>Haenisch</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Tomasik</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Ruland</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Rahmoune</surname>
<given-names>H</given-names></string-name>, <etal>et al.</etal>
<article-title>Applications of blood-based protein biomarker strategies in the study of psychiatric disorders</article-title>. <source/>Progr Neurobiol. <year>2014</year>;<volume>122</volume>:<fpage>45</fpage>–<lpage>72</lpage>.</mixed-citation>
</ref>
<ref id="r15">
<label>[15]</label>
<mixed-citation id="ref15" publication-type="journal"><string-name><surname>Ganz</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Heidecker</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Hveem</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Jonasson</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Kato</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Segal</surname>
<given-names>MR</given-names></string-name>, <etal>et al.</etal>
<article-title>Development and validation of a protein-based risk score for cardiovascular outcomes among patients with stable coronary heart disease</article-title>. <source/>JAMA. <year>2016</year>;<volume>315</volume>(<issue>23</issue>):<fpage>2532</fpage>–<lpage>2541</lpage>.<pub-id pub-id-type="pmid">27327800</pub-id></mixed-citation>
</ref>
<ref id="r16">
<label>[16]</label>
<mixed-citation id="ref16" publication-type="journal"><string-name><surname>Chan</surname>
<given-names>KC</given-names></string-name>, <string-name><surname>Lucas</surname>
<given-names>DA</given-names></string-name>, <string-name><surname>Hise</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Schaefer</surname>
<given-names>CF</given-names></string-name>, <string-name><surname>Xiao</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>Janini</surname>
<given-names>GM</given-names></string-name>, <etal>et al.</etal>
<article-title>Analysis of the human serum proteome</article-title>. <source/>Clin Proteomics. <year>2004</year>;<volume>1</volume>(<issue>2</issue>):<fpage>101</fpage>–<lpage>225</lpage>.</mixed-citation>
</ref>
<ref id="r17">
<label>[17]</label>
<mixed-citation id="ref17" publication-type="journal"><string-name><surname>Anderson</surname>
<given-names>NL</given-names></string-name>. <article-title>The clinical plasma proteome: a survey of clinical assays for proteins in plasma and serum</article-title>. <source/>Clin Chem. <year>2010</year>;<volume>56</volume>(<issue>2</issue>):<fpage>177</fpage>–<lpage>185</lpage>.<pub-id pub-id-type="pmid">19884488</pub-id></mixed-citation>
</ref>
<ref id="r18">
<label>[18]</label>
<mixed-citation id="ref18" publication-type="journal"><string-name><surname>Hye</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Lynham</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Thambisetty</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Causevic</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Campbell</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Byers</surname>
<given-names>HL</given-names></string-name>, <etal>et al.</etal>
<article-title>Proteome-based plasma biomarkers for Alzheimer’s disease</article-title>. <source/>Brain. <year>2006</year>;<volume>129</volume>(<issue>11</issue>):<fpage>3042</fpage>–<lpage>3050</lpage>.<pub-id pub-id-type="pmid">17071923</pub-id></mixed-citation>
</ref>
<ref id="r19">
<label>[19]</label>
<mixed-citation id="ref19" publication-type="journal"><string-name><surname>Sussulini</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Dihazi</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Banzato</surname>
<given-names>CEM</given-names></string-name>, <string-name><surname>Arruda</surname>
<given-names>MAZ</given-names></string-name>, <string-name><surname>Stühmer</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Ehrenreich</surname>
<given-names>H</given-names></string-name>, <etal>et al.</etal>
<article-title>Apolipoprotein A-I as a candidate serum marker for the response to lithium treatment in bipolar disorder</article-title>. <source/>Proteomics. <year>2011</year>;<volume>11</volume>(<issue>2</issue>):<fpage>261</fpage>–<lpage>269</lpage>.<pub-id pub-id-type="pmid">21204253</pub-id></mixed-citation>
</ref>
<ref id="r20">
<label>[20]</label>
<mixed-citation id="ref20" publication-type="journal"><string-name><surname>Dimas</surname>
<given-names>AS</given-names></string-name>, <string-name><surname>Deutsch</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Stranger</surname>
<given-names>BE</given-names></string-name>, <string-name><surname>Montgomery</surname>
<given-names>SB</given-names></string-name>, <string-name><surname>Borel</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Attar-Cohen</surname>
<given-names>H</given-names></string-name>, <etal>et al.</etal>
<article-title>Common regulatory variation impacts gene expression in a cell type-dependent manner</article-title>. <source/>Science. <year>2009</year>;<volume>325</volume>(<issue>5945</issue>):<fpage>1246</fpage>–<lpage>1250</lpage>.<pub-id pub-id-type="pmid">19644074</pub-id></mixed-citation>
</ref>
<ref id="r21">
<label>[21]</label>
<mixed-citation id="ref21" publication-type="journal"><string-name><surname>Hernandez</surname>
<given-names>DG</given-names></string-name>, <string-name><surname>Nalls</surname>
<given-names>MA</given-names></string-name>, <string-name><surname>Moore</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Chong</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Dillman</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Trabzuni</surname>
<given-names>D</given-names></string-name>, <etal>et al.</etal>
<article-title>Integration of GWAS SNPs and tissue specific expression profiling reveal discrete eQTLs for human traits in blood and brain</article-title>. <source/>Neurobiol Dis. <year>2012</year>;<volume>47</volume>(<issue>1</issue>):<fpage>20</fpage>–<lpage>28</lpage>.<pub-id pub-id-type="pmid">22433082</pub-id></mixed-citation>
</ref>
<ref id="r22">
<label>[22]</label>
<mixed-citation id="ref22" publication-type="journal"><string-name><surname>Foss</surname>
<given-names>EJ</given-names></string-name>, <string-name><surname>Radulovic</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Shaffer</surname>
<given-names>SA</given-names></string-name>, <string-name><surname>Ruderfer</surname>
<given-names>DM</given-names></string-name>, <string-name><surname>Bedalov</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Goodlett</surname>
<given-names>DR</given-names></string-name>, <etal>et al.</etal>
<article-title>Genetic basis of proteome variation in yeast</article-title>. <source/>Nat Genet. <year>2007</year>;<volume>39</volume>:<fpage>1369</fpage>.<pub-id pub-id-type="pmid">17952072</pub-id></mixed-citation>
</ref>
<ref id="r23">
<label>[23]</label>
<mixed-citation id="ref23" publication-type="journal"><string-name><surname>Bulik-Sullivan</surname>
<given-names>BK</given-names></string-name>, <string-name><surname>Loh</surname>
<given-names>PR</given-names></string-name>, <string-name><surname>Finucane</surname>
<given-names>HK</given-names></string-name>, <string-name><surname>Ripke</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Yang</surname>
<given-names>J</given-names></string-name>, <collab>Schizophrenia Working Group of the Psychiatric Genomics Consortium</collab>, <etal>et al.</etal>
<article-title>LD score regression distinguishes confounding from polygenicity in genome-wide association studies</article-title>. <source/>Nat Genet. <year>2015</year>;<volume>47</volume>:<fpage>291</fpage>.<pub-id pub-id-type="pmid">25642630</pub-id></mixed-citation>
</ref>
<ref id="r24">
<label>[24]</label>
<mixed-citation id="ref24" publication-type="journal"><string-name><surname>Lee</surname>
<given-names>JJ</given-names></string-name>, <string-name><surname>Chow</surname>
<given-names>CC</given-names></string-name>. <article-title>LD score regression as an estimator of confounding and genetic correlations in genome-wide association studies</article-title>. <source/>bioRxiv. <year>2017</year>;<fpage>234815</fpage>.</mixed-citation>
</ref>
<ref id="r25">
<label>[25]</label>
<mixed-citation id="ref25" publication-type="journal"><string-name><surname>Bulik-Sullivan</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Finucane</surname>
<given-names>HK</given-names></string-name>, <string-name><surname>Anttila</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Gusev</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Day</surname>
<given-names>FR</given-names></string-name>, <string-name><surname>Loh</surname>
<given-names>PR</given-names></string-name>, <etal>et al.</etal>
<article-title>An atlas of genetic correlations across human diseases and traits</article-title>. <source/>Nat Genet. <year>2015</year>;<volume>47</volume>(<issue>11</issue>):<fpage>1236</fpage>–<lpage>1241</lpage>.<pub-id pub-id-type="pmid">26414676</pub-id></mixed-citation>
</ref>
<ref id="r26">
<label>[26]</label>
<mixed-citation id="ref26" publication-type="journal"><string-name><surname>Duncan</surname>
<given-names>LE</given-names></string-name>, <string-name><surname>Ratanatharathorn</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Aiello</surname>
<given-names>AE</given-names></string-name>, <string-name><surname>Almli</surname>
<given-names>LM</given-names></string-name>, <string-name><surname>Amstadter</surname>
<given-names>AB</given-names></string-name>, <string-name><surname>Ashley-Koch</surname>
<given-names>AE</given-names></string-name>, <etal>et al.</etal>
<article-title>Largest GWAS of PTSD (<italic>N</italic> = 20,070) yields genetic overlap with schizophrenia and sex differences in heritability</article-title>. <source/>Mol Psychiatry. <year>2017</year>;<volume>23</volume>:<fpage>666</fpage>.<pub-id pub-id-type="pmid">28439101</pub-id></mixed-citation>
</ref>
<ref id="r27">
<label>[27]</label>
<mixed-citation id="ref27" publication-type="journal"><string-name><surname>Demontis</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Walters</surname>
<given-names>RK</given-names></string-name>, <string-name><surname>Martin</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Mattheisen</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Als</surname>
<given-names>TD</given-names></string-name>, <string-name><surname>Agerbo</surname>
<given-names>E</given-names></string-name>, <etal>et al.</etal>
<article-title>Discovery of the first genome-wide significant risk loci for ADHD</article-title>. <source/>bioRxiv. <year>2017</year>;<fpage>145581</fpage>.</mixed-citation>
</ref>
<ref id="r28">
<label>[28]</label>
<mixed-citation id="ref28" publication-type="journal"><string-name><surname>Anney</surname>
<given-names>RJL</given-names></string-name>, <string-name><surname>Ripke</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Anttila</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Grove</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Holmans</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Huang</surname>
<given-names>H</given-names></string-name>, <etal>et al.</etal>
<article-title>Meta-analysis of GWAS of over 16,000 individuals with autism spectrum disorder highlights a novel locus at 10q24.32 and a significant overlap with schizophrenia</article-title>. <source/>Mol Autism. <year>2017</year>;<volume>8</volume>(<issue>1</issue>):<fpage>21</fpage>.<pub-id pub-id-type="pmid">28540026</pub-id></mixed-citation>
</ref>
<ref id="r29">
<label>[29]</label>
<mixed-citation id="ref29" publication-type="journal"><string-name><surname>Ruderfer</surname>
<given-names>DM</given-names></string-name>, <string-name><surname>Ripke</surname>
<given-names>S</given-names></string-name>, <string-name><surname>McQuillin</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Boocock</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Stahl</surname>
<given-names>EA</given-names></string-name>, <string-name><surname>Pavlides</surname>
<given-names>JMW</given-names></string-name>, <etal>et al.</etal>
<article-title>Genomic dissection of bipolar disorder and schizophrenia, including 28 subphenotypes</article-title>. <source/>Cell. <year>2018</year>;<volume>173</volume>(<issue>7</issue>):<fpage>1705.e16</fpage>–<lpage>1715.e16</lpage>.<pub-id pub-id-type="pmid">29906448</pub-id></mixed-citation>
</ref>
<ref id="r30">
<label>[30]</label>
<mixed-citation id="ref30" publication-type="journal"><string-name><surname>Wray</surname>
<given-names>NR</given-names></string-name>, <string-name><surname>Ripke</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Mattheisen</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Trzaskowski</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Byrne</surname>
<given-names>EM</given-names></string-name>, <string-name><surname>Abdellaoui</surname>
<given-names>A</given-names></string-name>, <etal>et al.</etal>
<article-title>Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression</article-title>. <source/>Nat Genet. <year>2018</year>;<volume>50</volume>(<issue>5</issue>):<fpage>668</fpage>–<lpage>681</lpage>.<pub-id pub-id-type="pmid">29700475</pub-id></mixed-citation>
</ref>
<ref id="r31">
<label>[31]</label>
<mixed-citation id="ref31" publication-type="journal"><string-name><surname>Schork</surname>
<given-names>AJ</given-names></string-name>, <string-name><surname>Won</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Appadurai</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Nudel</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Gandal</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Delaneau</surname>
<given-names>O</given-names></string-name>, <etal>et al.</etal>
<article-title>A genome-wide association study of shared risk across psychiatric disorders implicates gene regulation during fetal neurodevelopment</article-title>. <source/>Nat Neurosci. <year>2019</year>;<volume>22</volume>:<fpage>353</fpage>–<lpage>361</lpage>.<pub-id pub-id-type="pmid">30692689</pub-id></mixed-citation>
</ref>
<ref id="r32">
<label>[32]</label>
<mixed-citation id="ref32" publication-type="journal"><string-name><surname>Angelantonio</surname>
<given-names>ED</given-names></string-name>, <string-name><surname>Thompson</surname>
<given-names>SG</given-names></string-name>, <string-name><surname>Kaptoge</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Moore</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Walker</surname>
<given-names>MP</given-names></string-name>, <string-name><surname>Armitage</surname>
<given-names>J</given-names></string-name>, <etal>et al.</etal>
<article-title>Efficiency and safety of varying the frequency of whole blood donation (INTERVAL): a randomised trial of 45 000 donors</article-title>. <source/>Lancet. <year>2017</year>;<volume>390</volume>(<issue>10110</issue>):<fpage>2360</fpage>–<lpage>2371</lpage>.<pub-id pub-id-type="pmid">28941948</pub-id></mixed-citation>
</ref>
<ref id="r33">
<label>[33]</label>
<mixed-citation id="ref33" publication-type="journal"><string-name><surname>Astle</surname>
<given-names>WJ</given-names></string-name>, <string-name><surname>Elding</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Jiang</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Allen</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Ruklisa</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Mann</surname>
<given-names>AL</given-names></string-name>, <etal>et al.</etal>
<article-title>The allelic landscape of human blood cell trait variation and links to common complex disease</article-title>. <source/>Cell. <year>2016</year>;<volume>167</volume>(<issue>5</issue>):<fpage>1415.e19</fpage>–<lpage>1429.e19</lpage>.<pub-id pub-id-type="pmid">27863252</pub-id></mixed-citation>
</ref>
<ref id="r34">
<label>[34]</label>
<mixed-citation id="ref34" publication-type="journal"><string-name><surname>Bulik-Sullivan</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Finucane</surname>
<given-names>HK</given-names></string-name>, <string-name><surname>Anttila</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Gusev</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Day</surname>
<given-names>FR</given-names></string-name>, <string-name><surname>Consortium</surname>
<given-names>R</given-names></string-name>, <etal>et al.</etal>
<article-title>An atlas of genetic correlations across human diseases and traits</article-title>. <source/>Nat Genet. <year>2015</year>;<volume>47</volume>:<fpage>1236</fpage>.<pub-id pub-id-type="pmid">26414676</pub-id></mixed-citation>
</ref>
<ref id="r35">
<label>[35]</label>
<mixed-citation id="ref35" publication-type="journal"><string-name><surname>Shi</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Kichaev</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Pasaniuc</surname>
<given-names>B</given-names></string-name>. <article-title>Contrasting the genetic architecture of 30 complex traits from summary association data</article-title>. <source/>Am J Hum Genet. <year>2016</year>;<volume>99</volume>(<issue>1</issue>):<fpage>139</fpage>–<lpage>153</lpage>.<pub-id pub-id-type="pmid">27346688</pub-id></mixed-citation>
</ref>
<ref id="r36">
<label>[36]</label>
<mixed-citation id="ref36" publication-type="journal"><string-name><surname>Chamberlain</surname>
<given-names>RS</given-names></string-name>, <string-name><surname>Herman</surname>
<given-names>BH</given-names></string-name>. <article-title>A novel biochemical model linking dysfunctions in brain melatonin, proopiomelanocortin peptides, and serotonin in autism</article-title>. <source/>Biol Psychiatry. <year>1990</year>;<volume>28</volume>(<issue>9</issue>):<fpage>773</fpage>–<lpage>793</lpage>.<pub-id pub-id-type="pmid">2175218</pub-id></mixed-citation>
</ref>
<ref id="r37">
<label>[37]</label>
<mixed-citation id="ref37" publication-type="journal"><string-name><surname>Leboyer</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Bouvard</surname>
<given-names>MP</given-names></string-name>, <string-name><surname>Recasens</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Philippe</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Guilloudbataille</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Bondoux</surname>
<given-names>D</given-names></string-name>, <etal>et al.</etal>
<article-title>Difference between plasma N- and C-terminally directed beta-endorphin immunoreactivity in infantile autism</article-title>. <source/>Am J Psychiatry. <year>1994</year>;<volume>151</volume>(<issue>12</issue>):<fpage>1797</fpage>–<lpage>1801</lpage>.<pub-id pub-id-type="pmid">7977888</pub-id></mixed-citation>
</ref>
<ref id="r38">
<label>[38]</label>
<mixed-citation id="ref38" publication-type="journal"><string-name><surname>Sandman</surname>
<given-names>CA</given-names></string-name>, <string-name><surname>Hetrick</surname>
<given-names>WP</given-names></string-name>, <string-name><surname>Taylor</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Chiczdemet</surname>
<given-names>A</given-names></string-name>. <article-title>Dissociation of POMC peptides after self-injury predicts responses to centrally acting opiate blockers</article-title>. <source/>Am J Mental Retard. <year>1997</year>;<volume>102</volume>(<issue>2</issue>):<fpage>182</fpage>–<lpage>199</lpage>.</mixed-citation>
</ref>
<ref id="r39">
<label>[39]</label>
<mixed-citation id="ref39" publication-type="journal"><string-name><surname>Cazzullo</surname>
<given-names>AG</given-names></string-name>, <string-name><surname>Musetti</surname>
<given-names>MC</given-names></string-name>, <string-name><surname>Musetti</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Bajo</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Sacerdote</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Panerai</surname>
<given-names>A</given-names></string-name>. <article-title>β-Endorphin levels in peripheral blood mononuclear cells and long-term naltrexone treatment in autistic children</article-title>. <source/>Eur Neuropsychopharmacol. <year>1999</year>;<volume>9</volume>(<issue>4</issue>):<fpage>361</fpage>–<lpage>366</lpage>.<pub-id pub-id-type="pmid">10422898</pub-id></mixed-citation>
</ref>
<ref id="r40">
<label>[40]</label>
<mixed-citation id="ref40" publication-type="journal"><string-name><surname>Sandman</surname>
<given-names>CA</given-names></string-name>, <string-name><surname>Spence</surname>
<given-names>MA</given-names></string-name>, <string-name>
<surname>Smith</surname>
</string-name>. <article-title>Proopiomelanocortin (POMC) disregulation and response to opiate blockers</article-title>. <source/>Mental Retardat Dev Disabil Res Rev. <year>1999</year>;<volume>5</volume>(<issue>4</issue>):<fpage>314</fpage>–<lpage>321</lpage>.</mixed-citation>
</ref>
<ref id="r41">
<label>[41]</label>
<mixed-citation id="ref41" publication-type="journal"><string-name><surname>Sandman</surname>
<given-names>CA</given-names></string-name>, <string-name><surname>Touchette</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Marion</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Lenjavi</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Chicz-Demet</surname>
<given-names>A</given-names></string-name>. <article-title>Disregulation of proopiomelanocortin and contagious maladaptive behavior</article-title>. <source/>Regul Peptid. <year>2002</year>;<volume>108</volume>(<issue>2</issue>):<fpage>179</fpage>–<lpage>185</lpage>.</mixed-citation>
</ref>
<ref id="r42">
<label>[42]</label>
<mixed-citation id="ref42" publication-type="journal"><string-name><surname>Tilleman</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Hakim</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Novikov</surname>
<given-names>O</given-names></string-name>, <string-name><surname>Liser</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Nashelsky</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Di Salvio</surname>
<given-names>M</given-names></string-name>, <etal>et al.</etal>
<article-title>Bmp5/7 in concert with the mid-hindbrain organizer control development of noradrenergic locus coeruleus neurons</article-title>. <source/>Mol Cell Neurosci. <year>2010</year>;<volume>45</volume>(<issue>1</issue>):<fpage>1</fpage>–<lpage>11</lpage>.<pub-id pub-id-type="pmid">20493948</pub-id></mixed-citation>
</ref>
<ref id="r43">
<label>[43]</label>
<mixed-citation id="ref43" publication-type="journal"><string-name><surname>Goridis</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Rohrer</surname>
<given-names>H</given-names></string-name>. <article-title>Specification of catecholaminergic and serotonergic neurons</article-title>. <source/>Nat Rev Neurosci. <year>2002</year>;<volume>3</volume>:<fpage>531</fpage>.<pub-id pub-id-type="pmid">12094209</pub-id></mixed-citation>
</ref>
<ref id="r44">
<label>[44]</label>
<mixed-citation id="ref44" publication-type="journal"><string-name><surname>Ordway</surname>
<given-names>GA</given-names></string-name>, <string-name><surname>Szebeni</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Chandley</surname>
<given-names>MJ</given-names></string-name>, <string-name><surname>Stockmeier</surname>
<given-names>CA</given-names></string-name>, <string-name><surname>Xiang</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Newton</surname>
<given-names>SS</given-names></string-name>, <etal>et al.</etal>
<article-title>Low gene expression of bone morphogenetic protein 7 in brainstem astrocytes in major depression</article-title>. <source/>Int J Neuropsychopharmacol. <year>2012</year>;<volume>15</volume>(<issue>7</issue>):<fpage>855</fpage>–<lpage>868</lpage>.<pub-id pub-id-type="pmid">21896235</pub-id></mixed-citation>
</ref>
<ref id="r45">
<label>[45]</label>
<mixed-citation id="ref45" publication-type="journal"><string-name><surname>Braff</surname>
<given-names>DL</given-names></string-name>, <string-name><surname>Grillon</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Geyer</surname>
<given-names>MA</given-names></string-name>. <article-title>Gating and habituation of the startle reflex in schizophrenic patients</article-title>. <source/>Archiv Gen Psychiatry. <year>1992</year>;<volume>49</volume>(<issue>3</issue>):<fpage>206</fpage>–<lpage>215</lpage>.</mixed-citation>
</ref>
<ref id="r46">
<label>[46]</label>
<mixed-citation id="ref46" publication-type="journal"><string-name><surname>Hakak</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Walker</surname>
<given-names>JR</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Wong</surname>
<given-names>WH</given-names></string-name>, <string-name><surname>Davis</surname>
<given-names>KL</given-names></string-name>, <string-name><surname>Buxbaum</surname>
<given-names>JD</given-names></string-name>, <etal>et al.</etal>
<article-title>Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia</article-title>. <source/>Proc Natl Acad Sci U S A. <year>2001</year>;<volume>98</volume>(<issue>8</issue>):<fpage>4746</fpage>–<lpage>4751</lpage>.<pub-id pub-id-type="pmid">11296301</pub-id></mixed-citation>
</ref>
<ref id="r47">
<label>[47]</label>
<mixed-citation id="ref47" publication-type="journal"><string-name><surname>Kim</surname>
<given-names>HJ</given-names></string-name>, <string-name><surname>Miron</surname>
<given-names>VE</given-names></string-name>, <string-name><surname>Dukala</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Proia</surname>
<given-names>RL</given-names></string-name>, <string-name><surname>Ludwin</surname>
<given-names>SK</given-names></string-name>, <string-name><surname>Traka</surname>
<given-names>M</given-names></string-name>, <etal>et al.</etal>
<article-title>Neurobiological effects of sphingosine 1-phosphate receptor modulation in the cuprizone model</article-title>. <source/>FASEB J. <year>2011</year>;<volume>25</volume>(<issue>5</issue>):<fpage>1509</fpage>–<lpage>1518</lpage>.<pub-id pub-id-type="pmid">21248243</pub-id></mixed-citation>
</ref>
<ref id="r48">
<label>[48]</label>
<mixed-citation id="ref48" publication-type="journal"><string-name><surname>Contos</surname>
<given-names>JJA</given-names></string-name>, <string-name><surname>Ishii</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Fukushima</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Kingsbury</surname>
<given-names>MA</given-names></string-name>, <string-name><surname>Ye</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Kawamura</surname>
<given-names>S</given-names></string-name>, <etal>et al.</etal>
<article-title>Characterization of lpa(2) (Edg4) and lpa(1)/lpa(2) (Edg2/Edg4) lysophosphatidic acid receptor knockout mice: signaling deficits without obvious phenotypic abnormality attributable to lpa(2)</article-title>. <source/>Mol Cell Biol. <year>2002</year>;<volume>22</volume>(<issue>19</issue>):<fpage>6921</fpage>–<lpage>6929</lpage>.<pub-id pub-id-type="pmid">12215548</pub-id></mixed-citation>
</ref>
<ref id="r49">
<label>[49]</label>
<mixed-citation id="ref49" publication-type="journal"><string-name><surname>Maceyka</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Harikumar</surname>
<given-names>KB</given-names></string-name>, <string-name><surname>Milstien</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Spiegel</surname>
<given-names>S</given-names></string-name>. <article-title>Sphingosine-1-phosphate signaling and its role in disease</article-title>. <source/>Trends Cell Biol. <year>2012</year>;<volume>22</volume>(<issue>1</issue>):<fpage>50</fpage>–<lpage>60</lpage>.<pub-id pub-id-type="pmid">22001186</pub-id></mixed-citation>
</ref>
<ref id="r50">
<label>[50]</label>
<mixed-citation id="ref50" publication-type="journal"><string-name><surname>Ho</surname>
<given-names>MC</given-names></string-name>, <string-name><surname>Nassan</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Balwinder</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Colby</surname>
<given-names>C</given-names></string-name>, <string-name><surname>McElroy</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Frye</surname>
<given-names>M</given-names></string-name>, <etal>et al.</etal>
<article-title>F125. Genome-wide association study of anti-epileptic drug mood stabilizer response in bipolar disorder patients</article-title>. <source/>Biol Psychiatry. <year>2018</year>;<volume>83</volume>(<issue>9</issue>):<fpage>S286</fpage>.</mixed-citation>
</ref>
<ref id="r51">
<label>[51]</label>
<mixed-citation id="ref51" publication-type="journal"><string-name><surname>Mitsuhiro</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Annie-Claire</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Isabelle</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Nicolas de</surname>
<given-names>T</given-names></string-name>. <article-title>Analysis of cytokine receptor messenger RNA expression in human glioblastoma cells and normal astrocytes by reverse-transcription polymerase chain reaction</article-title>. <source/>J Neurosurg. <year>1994</year>;<volume>80</volume>(<issue>6</issue>):<fpage>1063</fpage>–<lpage>1073</lpage>.<pub-id pub-id-type="pmid">7514661</pub-id></mixed-citation>
</ref>
<ref id="r52">
<label>[52]</label>
<mixed-citation id="ref52" publication-type="journal"><string-name><surname>Fontaine</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Mohandsaid</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Hanoteau</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Fuchs</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Pfizenmaier</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Eisel</surname>
<given-names>ULM</given-names></string-name>. <article-title>Neurodegenerative and neuroprotective effects of tumor necrosis factor (TNF) in retinal ischemia: opposite roles of TNF receptor 1 and TNF receptor 2</article-title>. <source/>J Neurosci. <year>2002</year>;<volume>22</volume>(<issue>7</issue>):<fpage>1</fpage>–<lpage>7</lpage>.<pub-id pub-id-type="pmid">11756482</pub-id></mixed-citation>
</ref>
<ref id="r53">
<label>[53]</label>
<mixed-citation id="ref53" publication-type="journal"><string-name><surname>Bruce</surname>
<given-names>AJ</given-names></string-name>, <string-name><surname>Boling</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Kindy</surname>
<given-names>MS</given-names></string-name>, <string-name><surname>Peschon</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Kraemer</surname>
<given-names>PJ</given-names></string-name>, <string-name><surname>Carpenter</surname>
<given-names>MK</given-names></string-name>, <etal>et al.</etal>
<article-title>Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors</article-title>. <source/>Nat Med. <year>1996</year>;<volume>2</volume>(<issue>7</issue>):<fpage>788</fpage>–<lpage>794</lpage>.<pub-id pub-id-type="pmid">8673925</pub-id></mixed-citation>
</ref>
<ref id="r54">
<label>[54]</label>
<mixed-citation id="ref54" publication-type="journal"><string-name><surname>Till</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Rosenstiel</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Krippnerheidenreich</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Mascheretticroucher</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Croucher</surname>
<given-names>PJP</given-names></string-name>, <string-name><surname>Schafer</surname>
<given-names>H</given-names></string-name>, <etal>et al.</etal>
<article-title>The Met-196 Arg variation of human tumor necrosis factor receptor 2 (TNFR2) affects TNF-α-induced apoptosis by impaired NF-κB signaling and target gene expression</article-title>. <source/>J Biol Chem. <year>2005</year>;<volume>280</volume>(<issue>7</issue>):<fpage>5994</fpage>–<lpage>6004</lpage>.<pub-id pub-id-type="pmid">15572357</pub-id></mixed-citation>
</ref>
<ref id="r55">
<label>[55]</label>
<mixed-citation id="ref55" publication-type="journal"><string-name><surname>Thabet</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Ben Nejma</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Zaafrane</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Gaha</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Ben Salem</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Romdhane</surname>
<given-names>A</given-names></string-name>, <etal>et al.</etal>
<article-title>Association of the Met-196-Arg variation of human tumor necrosis factor receptor 2 (TNFR2) with paranoid schizophrenia</article-title>. <source/>J Mol Neurosci. <year>2011</year>;<volume>43</volume>(<issue>3</issue>):<fpage>358</fpage>–<lpage>363</lpage>.<pub-id pub-id-type="pmid">20842464</pub-id></mixed-citation>
</ref>
<ref id="r56">
<label>[56]</label>
<mixed-citation id="ref56" publication-type="journal"><string-name><surname>Hoseth</surname>
<given-names>EZ</given-names></string-name>, <string-name><surname>Ueland</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Dieset</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Birnbaum</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Shin</surname>
<given-names>JH</given-names></string-name>, <string-name><surname>Kleinman</surname>
<given-names>JE</given-names></string-name>, <etal>et al.</etal>
<article-title>A study of TNF pathway activation in schizophrenia and bipolar disorder in plasma and brain tissue</article-title>. <source/>Schizophr Bull. <year>2017</year>;<volume>43</volume>(<issue>4</issue>):<fpage>881</fpage>–<lpage>890</lpage>.<pub-id pub-id-type="pmid">28049760</pub-id></mixed-citation>
</ref>
<ref id="r57">
<label>[57]</label>
<mixed-citation id="ref57" publication-type="journal"><string-name><surname>Doganavsargil-Baysal</surname>
<given-names>O</given-names></string-name>, <string-name><surname>Cinemre</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Aksoy</surname>
<given-names>UM</given-names></string-name>, <string-name><surname>Akbas</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Metin</surname>
<given-names>O</given-names></string-name>, <string-name><surname>Fettahoglu</surname>
<given-names>C</given-names></string-name>, <etal>et al.</etal>
<article-title>Levels of TNF-α, soluble TNF receptors (sTNFR1, sTNFR2), and cognition in bipolar disorder</article-title>. <source/>Hum Psychopharmacol Clin Exp. <year>2013</year>;<volume>28</volume>(<issue>2</issue>):<fpage>160</fpage>–<lpage>167</lpage>.</mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>